1652 SURVIVAL OUTCOMES OF PATIENTS WITH GROSSLY POSITIVE NODES AT RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER
Guilherme Godoy,Lambros Stamatakis,Robert Freundlich,Guoqing Chen,Anuja Mital,Jeffrey Shoss,Ramiro Madden-Fuentes,Bumshik Hong,Seth P. Lerner
DOI: https://doi.org/10.1016/j.juro.2010.02.1454
IF: 7.6
2010-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyBladder Cancer: Invasive/Metastatic Disease I1 Apr 20101652 SURVIVAL OUTCOMES OF PATIENTS WITH GROSSLY POSITIVE NODES AT RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER Guilherme Godoy, Lambros Stamatakis, Robert Freundlich, Guoqing Chen, Anuja Mital, Jeffrey Shoss, Ramiro Madden-Fuentes, Bumshik Hong, and Seth P. Lerner Guilherme GodoyGuilherme Godoy More articles by this author , Lambros StamatakisLambros Stamatakis More articles by this author , Robert FreundlichRobert Freundlich More articles by this author , Guoqing ChenGuoqing Chen More articles by this author , Anuja MitalAnuja Mital More articles by this author , Jeffrey ShossJeffrey Shoss More articles by this author , Ramiro Madden-FuentesRamiro Madden-Fuentes More articles by this author , Bumshik HongBumshik Hong More articles by this author , and Seth P. LernerSeth P. Lerner More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1454AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Extended pelvic lymph node dissection (ePLND) during radical cystectomy (RC) may provide more accurate staging and improved cancer control. There is controversy regarding the ideal management of patients when grossly positive LN are encountered during exploration and lymphadenectomy. The objective of this study was to analyze whether grossly positive LN during RC + ePLND was associated with adverse impact on overall and cancer specific survival (OS and CSS). METHODS From an Institution Review Board-approved database we identified 316 consecutive patients who underwent RC + ePLND by a single surgeon (SPL) between 1992 and 2009 for urothelial carcinoma of the bladder and had ePLND. The dissection included pelvic (hypogastric, obturator and external iliac) and common iliac, pre-sacral and pre-sciatic nodes with the proximal limit at or above the bifurcation of the aorta. Complete survival and minimum follow-up time of 12 months were available in 260 patients who constituted the final study group. Cox's proportional hazard models and Kaplan-Meier plots were used for the survival analyses. RESULTS The median time to follow-up for patients alive at the time of analysis was 45 months (IQR 19, 75). Median age was 66 years (IQR 58, 74) and 84.2% were males. Pathologic stage was pT0-T1, pT2, pT3 and pT4 in 40.4%, 21.9%, 28.5% and 9.2%, respectively. A median of 29 LN were removed (IQR 21, 40) and 61 (23.5%) patients had pathologic LN metastasis. The proportion of pN1, pN2 and pN3 was 29.5%, 59% and 11.5%, respectively. Sixty-six patients (25.4%) had grossly positive LN, of which 7 (2.7%) were negative in the final pathology. Grossly positive LN was a significant predictor of both OS and CSS in univariable analysis. Estimated 5-year OS and CSS for patients with grossly positive LN was 42.9% vs. 74.3% and 55.7% vs. 90.6%, respectively (both log-ranks <0.0001 vs. grossly negative LN). The 5-year OS and CSS estimates for pN+ were 41.7% vs.74.1% and 53.9% vs. 90.7%, respectively (both log-ranks <0.0001 vs. pN0). After controlling for age, pT- and pN-stage, only age and pN-stage were independent predictors of OS and CSS, respectively. CONCLUSIONS When controlled for age and pathologic stage, the presence of grossly positive LN during RCP does not constitute a risk factor for worse OS and CSS. These findings suggest that when grossly positive LNs are resectable, the procedure should continue to completion of the RCP+PLND. Houston, TX© 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e638 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Guilherme Godoy More articles by this author Lambros Stamatakis More articles by this author Robert Freundlich More articles by this author Guoqing Chen More articles by this author Anuja Mital More articles by this author Jeffrey Shoss More articles by this author Ramiro Madden-Fuentes More articles by this author Bumshik Hong More articles by this author Seth P. Lerner More articles by this author Expand All Advertisement Advertisement PDF DownloadLoading ...